ForthRight Wealth Management’s McKesson MCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$431K Sell
498
-105
-17% -$93.7K 0.12% 50
2025
Q4
$495K Hold
603
0.14% 46
2025
Q3
$466K Sell
603
-50
-8% -$35.2K 0.14% 46
2025
Q2
$479K Buy
653
+102
+19% +$72K 0.15% 44
2025
Q1
$371K Hold
551
0.12% 45
2024
Q4
$314K Hold
551
0.1% 51
2024
Q3
$272K Sell
551
-59
-10% -$32.9K 0.09% 56
2024
Q2
$356K Sell
610
-16
-3% -$8.91K 0.13% 47
2024
Q1
$336K Hold
626
0.12% 48
2023
Q4
$290K Sell
626
-19
-3% -$8.64K 0.11% 49
2023
Q3
$280K Sell
645
-15
-2% -$6.32K 0.12% 46
2023
Q2
$282K Hold
660
0.12% 44
2023
Q1
$235K Hold
660
0.11% 48
2022
Q4
$248K Hold
660
0.13% 45
2022
Q3
$224K Hold
660
0.13% 42
2022
Q2
$215K Sell
660
-66
-9% -$21.1K 0.12% 42
2022
Q1
$222K Buy
+726
New +$197K 0.11% 41
2021
Q1
Sell
-726
Closed -$126K 126
2020
Q4
$126K Buy
+726
New +$121K 0.1% 40

Other funds holding MCK

ForthRight Wealth Management's MCK Position: Q1 2026 in Review

ForthRight Wealth Management reduced its McKesson (MCK) stake by 17% in Q1 2026, selling an estimated $93.7K and leaving 498 shares worth $431K. The position accounts for 0.12% of the portfolio, ranked #50.

ForthRight Wealth Management first reported a position in MCK in Q4 2020 and has held it in 18 quarters since. The position peaked at $495K in Q4 2025. 2,032 funds tracked by Wall St. Rank hold MCK as of Q1 2026.

  • ForthRight Wealth Management held 498 shares of McKesson worth $431K as of Q1 2026.
  • ForthRight Wealth Management sold 105 McKesson shares in Q1 2026, an estimated $93.7K.
  • McKesson made up 0.12% of ForthRight Wealth Management's portfolio in Q1 2026, its #50 holding.
  • ForthRight Wealth Management first reported a position in McKesson in Q4 2020 and has held it in 18 quarters since.
  • ForthRight Wealth Management's McKesson position peaked at $495K in Q4 2025.
  • 2,032 funds tracked by Wall St. Rank held McKesson as of Q1 2026.

Based on ForthRight Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.